If you require special assistance to attend this event, please call Kim Page at (859) 218-0340.
An Equal Opportunity University.
This innovative, educational activity is designed to help healthcare professionals provide optimal management for their patients with castration-resistant prostate cancer (CRPC) with a particular focus on advanced metastatic disease (mCRPC). P3 is designed to provide local HCPs with tailored, practical information that will support them in developing evidence-based, individualized mCRPC treatment strategies.
William Oh, MDChief, Hematology and Medical Oncology
Professor, Medicine and Urology
Ezra M. Greenspan MD Professor, Clinical Cancer Therapeutics
Mount Sinai School of Medicine
Associate Director, Clinical Research
The Tisch Cancer Institute
New York, New York View Full Bio
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and Remedica Medical Education and Publishing, Ltd.. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.The University of Kentucky College of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Patient care
- Medical knowledge
- Practice-based learning and improvement
UK Healthcare CECentral certifies this activity for 2.00 hours of participation.